140 related articles for article (PubMed ID: 7838305)
1. Beta amyloid neurotoxicity and neuronal degeneration in Alzheimer's disease.
Kowall NW
Neurobiol Aging; 1994; 15(2):257-8. PubMed ID: 7838305
[No Abstract] [Full Text] [Related]
2. Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments.
Kaneko I; Morimoto K; Kubo T
Neuroscience; 2001; 104(4):1003-11. PubMed ID: 11457586
[TBL] [Abstract][Full Text] [Related]
3. [Morphology and neurotoxicity of newly identified spherical beta-amyloid aggregates, 'amylospheroid', aiming at elucidation of the neurodegenerative cascades in Alzheimer's disease].
Hoshi M
Seikagaku; 2004 Jul; 76(7):631-9. PubMed ID: 15346899
[No Abstract] [Full Text] [Related]
4. Fibrillar amyloid-beta affects neurofibrillary changes but only in neurons already involved in neurofibrillary degeneration.
Wegiel J; Bobinski M; Tarnawski M; Dziewiatkowski J; Popovitch E; Miller DC; Wisniewski T; Golomb J; de Leon MJ; Reisberg B
Acta Neuropathol; 2001 Jun; 101(6):585-90. PubMed ID: 11515787
[TBL] [Abstract][Full Text] [Related]
5. Neurotoxicity of beta-amyloid and prion peptides.
Forloni G
Curr Opin Neurol; 1996 Dec; 9(6):492-500. PubMed ID: 9007411
[TBL] [Abstract][Full Text] [Related]
6. Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading. A. Brun & E. Englund. Histopathology 1981; 5; 549-564.
Brun A; Englund E
Histopathology; 2002 Sep; 41(3A):37-8, discussion 38-9. PubMed ID: 12405927
[No Abstract] [Full Text] [Related]
7. Cultured GABA-immunoreactive neurons are resistant to toxicity induced by beta-amyloid.
Pike CJ; Cotman CW
Neuroscience; 1993 Sep; 56(2):269-74. PubMed ID: 8247260
[TBL] [Abstract][Full Text] [Related]
8. Neurotoxicity of human amylin in rat primary hippocampal cultures: similarity to Alzheimer's disease amyloid-beta neurotoxicity.
May PC; Boggs LN; Fuson KS
J Neurochem; 1993 Dec; 61(6):2330-3. PubMed ID: 8245987
[TBL] [Abstract][Full Text] [Related]
9. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ.
Lassmann H; Bancher C; Breitschopf H; Wegiel J; Bobinski M; Jellinger K; Wisniewski HM
Acta Neuropathol; 1995; 89(1):35-41. PubMed ID: 7709729
[TBL] [Abstract][Full Text] [Related]
10. The search for diagnostic criteria in Alzheimer's disease: an update.
Prayson RA; Estes ML
Cleve Clin J Med; 1994; 61(2):115-22; quiz 162. PubMed ID: 8194175
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of Alzheimer's disease and dementia.
Bugiani O
Rev Neurol (Paris); 1999; 155 Suppl 4():S28-32. PubMed ID: 10637935
[TBL] [Abstract][Full Text] [Related]
12. [Perspectives on the amyloid cascade hypothesis of Alzheimer's disease].
Simón AM; Frechilla D; del Río J
Rev Neurol; 2010 Jun; 50(11):667-75. PubMed ID: 20514639
[TBL] [Abstract][Full Text] [Related]
13. Relationship between plaques, tangles, and dystrophic processes in Alzheimer's disease.
Trojanowski JQ; Shin RW; Schmidt ML; Lee VM
Neurobiol Aging; 1995; 16(3):335-40; discussion 341-5. PubMed ID: 7566343
[No Abstract] [Full Text] [Related]
14. A cellular mechanism for the neuronal changes underlying Alzheimer's disease.
Vickers JC
Neuroscience; 1997 Jun; 78(3):629-39. PubMed ID: 9153646
[No Abstract] [Full Text] [Related]
15. Brain prolyl oligopeptidase activity is associated with neuronal damage rather than beta-amyloid accumulation.
Laitinen KS; van Groen T; Tanila H; Venäläinen J; Männistö PT; Alafuzoff I
Neuroreport; 2001 Oct; 12(15):3309-12. PubMed ID: 11711876
[TBL] [Abstract][Full Text] [Related]
16. Protein folding, nucleation phenomena and delayed neurodegeneration in Alzheimer's disease.
Fox N; Harvey RJ; Rossor MN
Rev Neurosci; 1996; 7(1):21-8. PubMed ID: 8736676
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect?
Dickson DW
J Clin Invest; 2004 Jul; 114(1):23-7. PubMed ID: 15232608
[TBL] [Abstract][Full Text] [Related]
18. Mechanism and prevention of neurotoxicity caused by beta-amyloid peptides: relation to Alzheimer's disease.
Blanchard BJ; Konopka G; Russell M; Ingram VM
Brain Res; 1997 Nov; 776(1-2):40-50. PubMed ID: 9439794
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease.
Griffin WS; Mrak RE
J Leukoc Biol; 2002 Aug; 72(2):233-8. PubMed ID: 12149413
[TBL] [Abstract][Full Text] [Related]
20. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
